1 Department of Biochemistry and.
Am J Respir Crit Care Med. 2013 Sep 15;188(6):673-83. doi: 10.1164/rccm.201302-0342OC.
Shifts in the gene expression of nuclear protein in chronic obstructive pulmonary disease (COPD), a progressive disease that is characterized by extensive lung inflammation and apoptosis, are common; however, the extent of the elevation of the core histones, which are the major components of nuclear proteins and their consequences in COPD, has not been characterized, which is important because extracellular histones are cytotoxic to endothelial and airway epithelial cells.
To investigate the role of extracellular histones in COPD disease progression.
We analyzed the nuclear lung proteomes of ex-smokers with and without the disease. Further studies on the consequences of H3.3 were also performed.
A striking finding was a COPD-specific eightfold increase of hyperacetylated histone H3.3. The hyperacetylation renders H3.3 resistant to proteasomal degradation despite ubiquitination; when combined with the reduction in proteasome activity that is known for COPD, this resistance helps account for the increased levels of H3.3. Using anti-H3 antibodies, we found H3.3 in the airway lumen, alveolar fluid, and plasma of COPD samples. H3.3 was cytotoxic to lung structural cells via a mechanism that involves the perturbation of Ca(2+) homeostasis and mitochondrial toxicity. We used the primary human airway epithelial cells and found that the antibodies to either the C or N terminus of H3 could partially reverse H3.3 toxicity.
Our data indicate that there is an uncontrolled positive feedback loop in which the damaged cells release acetylated H3.3, which causes more damage, adds H3.3 release, and contributes toward the disease progression.
慢性阻塞性肺疾病(COPD)是一种进行性疾病,其特征为广泛的肺部炎症和细胞凋亡,核蛋白的基因表达发生变化较为常见;然而,核心组蛋白(核蛋白的主要组成部分)的升高程度及其在 COPD 中的后果尚未得到描述,这一点很重要,因为细胞外组蛋白对内皮细胞和气道上皮细胞具有细胞毒性。
研究细胞外组蛋白在 COPD 疾病进展中的作用。
我们分析了有和没有该疾病的戒烟者的肺核蛋白组。还对 H3.3 的后果进行了进一步研究。
一个显著的发现是 COPD 特异性的组蛋白 H3.3 乙酰化增加了 8 倍。这种乙酰化使得 H3.3 尽管被泛素化但仍能抵抗蛋白酶体降解;当与已知 COPD 中蛋白酶体活性降低相结合时,这种抗性有助于解释 H3.3 水平的增加。使用抗 H3 抗体,我们在 COPD 样本的气道腔、肺泡液和血浆中发现了 H3.3。H3.3 通过涉及钙(Ca2+)稳态和线粒体毒性紊乱的机制对肺结构细胞具有细胞毒性。我们使用原代人气道上皮细胞发现,针对 H3 的 C 或 N 末端的抗体可部分逆转 H3.3 的毒性。
我们的数据表明,存在一个失控的正反馈循环,其中受损细胞释放乙酰化 H3.3,这会导致更多的损伤,增加 H3.3 的释放,并促进疾病进展。